The number of medicinal cannabis prescriptions approved by the Therapeutic Goods Administration (TGA) in April has dropped to 6,682 from March’s record high of 9,959.

The TGA has now approved more than 116,000 SAS-B applications for unapproved medicinal cannabis products up to April 30, 2021.

One theory advanced for the high numbers in February and March was that Australia’s flower shortage meant doctors were seeking reapprovals for the same patient after their first choice product could not be sourced.

SAS-B approvals over the past 12 months

There were 279 Authorised Prescribers as at April 30, 2021, up from 215 in February.